Trials / Completed
CompletedNCT01722604
Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | brinzolamide 1% ophthalmic suspension | brinzolamide 1% ophthalmic suspension |
| DRUG | Azopt 1% | Azopt 1%, RLD |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-11-07
- Last updated
- 2023-05-09
- Results posted
- 2021-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01722604. Inclusion in this directory is not an endorsement.